Symbol
Lyell Immunopharma, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$12.82
Current price of the stock
$32K
Trading volume of the stock
$3.3B
Market capitalization of the company
Mid Cap
Category of market capitalization
15.87%
Long-term growth mean estimate
2.67
Mean analyst rating
-14.20%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
13.43
Current ratio
100.00%
Gross profit margin
-148544.10%
Operating profit margin
-148544.10%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-131126.50%
Pretax profit margin
-131126.50%
Net profit margin
-8.40%
Measures profitability relative to shareholders' equity
-8.40%
ROE excluding intangible assets
-7.20%
Measures profitability relative to total assets
-8.40%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-16.23
Measures valuation relative to earnings
-
P/E based on future earnings estimates
52156.85
Measures valuation relative to sales
6.20
Measures valuation relative to book value
-8.11
Measures valuation relative to operating cash flow
-8.04
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
